The role of sodium glucose cotransporter or glucagon-like peptide-1 receptor agonists in treating heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus

Background. Heart failure with preserved ejection fraction is not a single disease but a clinical syndrome secondary to important comorbidities, is increasing in prevalence, and is associated with high functional impairment. This study aimed to compare the results of treating patients with heart fai...

Full description

Bibliographic Details

Published in:	Romanian Journal of Medical Practice
Main Authors:	Laura Lungeanu-Juravle, Mirela Tache, Ana Radu, Carmen Dobjanschi, Petrisor Adamescu, Andra Nica, Emilia Rusu, Gabriela Radulian
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2024-03-01
Subjects:	heart failure with preserved ejection fraction (hfpef) diabetes mellitus type 2 (t2dm) n‐terminal pro–b‐type natriuretic peptide (ntprobnp) glucagon-like peptide-1 receptor agonists (glp-1 ras) sodium glucose cotransporter inhibitors (sglt-2 inhibitors)
Online Access:	https://rjmp.com.ro/articles/2024.1/RJMP_2024_1_Art-02.pdf